A dog carrying mutations in <i>AVP-NPII</i> exhibits key features of central diabetes insipidus

Huijuan Xu; Haiyang Hao; Shirui Wang; Xueru Liu; Wen Lyu; Zhentao Zuo; Yan Zhuo; Jidong Mi; Yong Q. Zhang; Rui Tian; Huijuan Zhu

doi:10.1016/j.jgg.2022.11.003

Volume 50 Issue 4

Apr. 2023

Turn off MathJax

Article Contents

Article Navigation > Journal of Genetics and Genomics > 2023 > 50(4): 280-283

PDF( 953 KB)

A dog carrying mutations in AVP-NPII exhibits key features of central diabetes insipidus

doi: 10.1016/j.jgg.2022.11.003

Huijuan Xu^1,2,
Haiyang Hao³,
Shirui Wang¹⁶,
Xueru Liu^18,19,
Wen Lyu^4,5,
Zhentao Zuo^6,7,8,
Yan Zhuo⁹,
Jidong Mi¹⁰,
Yong Q. Zhang^13,14,
Rui Tian¹¹,
Huijuan Zhu¹²

1. State Key Laboratory for Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing 100101, China;
2. College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, China;
3. Beijing Sinogene Biotechnology Co. Ltd, Beijing 100005, China;
4. College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, China;
5. State Key Laboratory for Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing 100101, China;
6. College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, China;
7. State Key Laboratory of Brain and Cognitive Science, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China;
8. Hefei Comprehensive National Science Center, Institute of Artificial Intelligence, Hefei, Anhui 230088, China;
9. State Key Laboratory of Brain and Cognitive Science, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China;
10. Beijing Sinogene Biotechnology Co. Ltd, Beijing 100005, China;
11. State Key Laboratory for Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing 100101, China;
12. Department of Endocrinology, Peking Union Medical College Hospital, Beijing 100730, China;
13. College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, China;
14. State Key Laboratory for Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing 100101, China;
16. Department of Endocrinology, Peking Union Medical College Hospital, Beijing 100730, China;
18. College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, China;
19. State Key Laboratory of Brain and Cognitive Science, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China

Funds:

We thank Hui Zhao and Yi Ding for discussion, Liang Wu, Qiqi Wang, and Junzheng Shi for assistance in experiments. This work was supported by grants from the National Key Research and Development Program (2019YFA0707100 and 2021ZD0203901 to Y.Q. Zhang and R. Tian), the Strategic Priority Research Program B of the Chinese Academy of Sciences (XDBS1020100 to Y.Q. Zhang), the National Science Foundation of China (31830036 and 31921002 to Y.Q. Zhang).

Received Date: 2022-08-25
Accepted Date: 2022-11-02
Rev Recd Date: 2022-11-02
Publish Date: 2023-04-30

Abstract

FullText(HTML)

References(17)

References

[1]	Atila, C., Loughrey, P.B., Garrahy, A., Winzeler, B., Refardt, J., Gildroy, P., Hamza, M., Pal, A., Verbalis, J.G., Thompson, C.J., et al. (2022). Central diabetes insipidus from a patient's perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey. Lancet Diabetes Endocrinol 10, 700-709.
[2]	Aulinas, A., Plessow, F., Asanza, E., Silva, L., Marengi, D.A., Fan, W., Abedi, P., Verbalis, J., Tritos, N.A., Nachtigall, L., et al. (2019). Low Plasma Oxytocin Levels and Increased Psychopathology in Hypopituitary Men With Diabetes Insipidus. The Journal of clinical endocrinology and metabolism 104, 3181-3191.
[3]	Christ-Crain, M., Bichet, D.G., Fenske, W.K., Goldman, M.B., Rittig, S., Verbalis, J.G., and Verkman, A.S. (2019). Diabetes insipidus. Nat Rev Dis Primers 5, 54.
[4]	Christ-Crain, M., Winzeler, B., and Refardt, J. (2021). Diagnosis and management of diabetes insipidus for the internist: an update. J Intern Med 290, 73-87.
[5]	Donaldson, Z.R., and Young, L.J. (2008). Oxytocin, vasopressin, and the neurogenetics of sociality. Science 322, 900-904.
[6]	Feng, C., Wang, X., Shi, H., Yan, Q., Zheng, M., Li, J., Zhang, Q., Qin, Y., Zhong, Y., Mi, J., et al. (2018). Generation of ApoE deficient dogs via combination of embryo injection of CRISPR/Cas9 with somatic cell nuclear transfer. J Genet Genomics 45, 47-50.
[7]	Garcia-Castano, A., Madariaga, L., Perez de Nanclares, G., Vela, A., Rica, I., Gaztambide, S., Martinez, R., Martinez de LaPiscina, I., Urrutia, I., Aguayo, A., et al. (2020). Forty-One Individuals With Mutations in the AVP-NPII Gene Associated With Familial Neurohypophyseal Diabetes Insipidus. J Clin Endocrinol Metab 105(4):1112-1118.
[8]	Gudinchet, F., Brunelle, F., Barth, M.O., Taviere, V., Brauner, R., Rappaport, R., and Lallemand, D. (1989). MR imaging of the posterior hypophysis in children. AJR Am J Roentgenol 153, 351-354.
[9]	Hong, H., Zhao, Z., Huang, X., Guo, C., Zhao, H., Wang, G.D., Zhang, Y.P., Zhao, J.P., Shi, J., Wu, Q.F., et al. (2022). Comparative Proteome and Cis-Regulatory Element Analysis Reveals Specific Molecular Pathways Conserved in Dog and Human Brains. Mol Cell Proteomics 21, 100261.
[10]	Mahia, J., and Bernal, A. (2021). Animal models for diabetes insipidus. Handb Clin Neurol 181, 275-288.
[11]	Russell, T.A., Ito, M., Ito, M., Yu, R.N., Martinson, F.A., Weiss, J., and Jameson, J.L. (2003). A murine model of autosomal dominant neurohypophyseal diabetes insipidus reveals progressive loss of vasopressin-producing neurons. Journal of Clinical Investigation 112, 1697-1706.
[12]	Teshima, T., Hara, Y., Masuda, H., Taoda, T., Nezu, Y., Harada, Y., Yogo, T., Hasegawa, D., Orima, H., Osamura, R.Y., et al. (2008). Relationship between arginine vasopressin and high signal intensity in the pituitary posterior lobe on T1-weighted MR images in dogs. The Journal of veterinary medical science 70, 693-699.
[13]	Tsai, K.L., Clark, L.A., and Murphy, K.E. (2007). Understanding hereditary diseases using the dog and human as companion model systems. Mamm Genome 18, 444-451.
[14]	Turkkahraman, D., Saglar, E., Karaduman, T., and Mergen, H. (2015). AVP-NPII gene mutations and clinical characteristics of the patients with autosomal dominant familial central diabetes insipidus. Pituitary 18, 898-904.
[15]	Valtin, H., and Schroeder, H.A. (1964). Familial Hypothalamic Diabetes Insipidus in Rats (Brattleboro Strain). Am J Physiol 206, 425-430.
[16]	Yang, H., Yan, K., Wang, L., Gong, F., Jin, Z., and Zhu, H. (2019). Autosomal dominant familial neurohypophyseal diabetes insipidus caused by a novel nonsense mutation in AVP-NPII gene. Exp Ther Med 18, 1309-1314.
[17]	Zhao, H., Zhao, J., Wu, D., Sun, Z., Hua, Y., Zheng, M., Liu, Y., Yang, Q., Huang, X., Li, Y., et al. (2021). Dogs lacking Apolipoprotein E show advanced atherosclerosis leading to apparent clinical complications. Sci China Life Sci 65(7), 1342-1356.